Aralia Racemosa MT
ARALIA RACEMOSA
ORAL
HUMAN PRESCRIPTION DRUG
Aralia Racemosa MT is an FDA drug label for the active ingredient ARALIA RACEMOSA manufactured by OHM PHARMA INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20211228.
- Generic name
- ARALIA RACEMOSA
- Manufacturer
- OHM PHARMA INC.
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 66096-751
- Application
- N/A
- Label effective
- 20211228
Active ingredients
Active Ingredient: Aralia Racemosa MT
Indications & Usage
Batch no. 40021 Restest Date: 11/2022
Dosage & Administration
Not available.
Contraindications
Not available.
Warnings
Caution: for manufacturing,processing or repacking only. Caution: for manufacturing, processing or repacking only.
Adverse Reactions
Not available.